{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:16:31Z","timestamp":1788149791290,"version":"build-2803163510"},"reference-count":5,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.medcli.2026.107530","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T18:49:35Z","timestamp":1782586175000},"page":"107530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uso concomitante de risankizumab en la psoriasis moderada \/ grave inducida por ofatumumab en un paciente con esclerosis m\u00faltiple remitente \/ recurrente"],"prefix":"10.1016","volume":"166","author":[{"given":"Ricardo","family":"Ruiz-Villaverde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cebolla-Verdugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Llamas-Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107530_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1595947","article-title":"Case Report: Severe psoriasis skin lesions following ofatumumab treatment for multiple sclerosis","volume":"16","author":"\u017bukowicz-Wyrwa","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2026.107530_bib0035","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/13524585241260564","article-title":"Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosis","volume":"30","author":"K\u00f6lsche","year":"2024","journal-title":"Mult Scler"},{"key":"10.1016\/j.medcli.2026.107530_bib0040","doi-asserted-by":"crossref","DOI":"10.1111\/srt.13662","article-title":"Induction of psoriatic scalp and nail lesions in a patient treated with ofatumumab: A potential autoimmune dysregulation induced by anti-CD20 therapy","volume":"30","author":"Herzum","year":"2024","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.medcli.2026.107530_bib0045","doi-asserted-by":"crossref","first-page":"e846","DOI":"10.1111\/1346-8138.17846","article-title":"Exacerbation of psoriasis during treatment with ofatumumab for multiple sclerosis","volume":"52","author":"Watabe","year":"2025","journal-title":"J Dermatol"},{"key":"10.1016\/j.medcli.2026.107530_bib0050","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/ijms25010583","article-title":"Breg-mediated immunoregulation in the skin","volume":"25","author":"Zheremyan","year":"2024","journal-title":"Int J Mol Sci"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326001806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326001806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T03:53:03Z","timestamp":1788148383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775326001806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0025775326001806"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107530","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uso concomitante de risankizumab en la psoriasis moderada \/ grave inducida por ofatumumab en un paciente con esclerosis m\u00faltiple remitente \/ recurrente","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107530"}}